• Empower Clinics (CSE:CBDT) is expanding COVID-19 testing days at its clinics, in order to meet rising demand in Arizona
  • The company conducted 2,130 physician-patient consultations in June, setting a new record for patient volumes 
  • In the last week alone, Arizona has reported nearly 25,000 COVID-19 cases, over a quarter of the state’s total cases
  • In related news, the company will not meet the deadline to file its annual filings, due to COVID-19’s ongoing impacts
  • Empower Clinics (CBDT) is up 9.09 per cent and is currently trading at C$0.06 per share

Empower Clinics (CSE:CBDT) is expanding COVID-19 testing days at its clinics, in order to meet rising demand in Arizona.

Back in late April, the cannabis company began conducting COVID-19 antibody testing at its Sun Valley Health clinics in Phoenix. Empower is now expanding its testing days to five days a week, in response to increasing demand across the state. 

During June 2020, the company conducted 2,130 physician-patient consultations at its clinics. This has set a new historic record for patient volumes for the month of June.

According to the Arizona Department of Health Services, nearly 25,000 positive COVID-19 cases have been reported in the last week. In total, the number of reported COVID-19 cases in Arizona has exceeded 87,000 people. 

Cases from the last week alone represent over 25 per cent of the state’s total reported cases.

Empower Clinics’ CEO, Steve McAuley, commented on the essential service it is currently providing in the midst of the pandemic.

“As a company and a health & wellness clinic operator, we are fortunate to be able to provide care and support to our thousands of patients every month.

“The demand for our services are at an all-time high, requiring us to hire new staff and extend hours of operation. Our team continues to perform with complete professionalism and safety, knowing the importance of the physician consultations we provide,” he said.

In related news, Empower Clinics is also grappling with another unfortunate side-effect of the COVID-19 pandemic. Like countless others, the company is unable to meet the deadline to file its annual filings, due to coronavirus-related disruptions.

Empower attributed this delay to the virus’ impacts, and to additional audit requirements by the company’s auditor, MNP, LLP. The company expects to file the annual filings by no later than July 15, 2020. 

Empower Clinics (CBDT) is up 9.09 per cent and is trading at C$0.06 per share at 11:52am EDT.

More From The Market Online
Cannabis Report image of farmed cannabis plants

The Market Online’s Weekly Cannabis Report – July 26, 2024

Tilray Oral Solution THC10:CBD10 cannabis extract, aka Tilray Solução Oral THC10:CBD10, has been approved for medical use in Portugal.
medical branch logo

Tilray approved for third medical cannabis product in Portugal

Tilray Medical, a subsidiary of Tilray Brands (TSX:TLRY) has been approved for a new medical cannabis extract in Portugal.